MALACRIDA, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 7.433
NA - Nord America 6.888
EU - Europa 3.224
SA - Sud America 627
Continente sconosciuto - Info sul continente non disponibili 574
AF - Africa 115
OC - Oceania 16
Totale 18.877
Nazione #
US - Stati Uniti d'America 6.570
VN - Vietnam 3.746
SG - Singapore 1.426
IT - Italia 1.067
CN - Cina 878
HK - Hong Kong 513
DE - Germania 504
BR - Brasile 494
RU - Federazione Russa 414
CA - Canada 240
SE - Svezia 224
GB - Regno Unito 194
IN - India 166
KR - Corea 144
IE - Irlanda 133
FR - Francia 131
ID - Indonesia 107
AT - Austria 100
BD - Bangladesh 98
FI - Finlandia 70
UA - Ucraina 64
LT - Lituania 53
JP - Giappone 51
MX - Messico 46
AR - Argentina 45
DK - Danimarca 45
ES - Italia 45
IQ - Iraq 41
NL - Olanda 40
TR - Turchia 39
SA - Arabia Saudita 37
PL - Polonia 36
TW - Taiwan 36
ZA - Sudafrica 36
BE - Belgio 30
PK - Pakistan 26
EC - Ecuador 22
CH - Svizzera 21
PH - Filippine 18
VE - Venezuela 17
CO - Colombia 16
MY - Malesia 16
AU - Australia 15
MA - Marocco 15
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
KE - Kenya 13
UZ - Uzbekistan 12
RO - Romania 11
PY - Paraguay 10
TN - Tunisia 10
CL - Cile 9
JM - Giamaica 9
KZ - Kazakistan 8
AZ - Azerbaigian 7
GR - Grecia 7
CR - Costa Rica 6
NP - Nepal 6
HN - Honduras 5
OM - Oman 5
PE - Perù 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
EU - Europa 4
UG - Uganda 4
UY - Uruguay 4
CY - Cipro 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
LY - Libia 2
NG - Nigeria 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
Totale 18.290
Città #
Ann Arbor 1.168
Ho Chi Minh City 1.167
Hanoi 952
Singapore 842
Dallas 835
San Jose 618
Ashburn 589
Hong Kong 500
Milan 379
Frankfurt am Main 363
Wilmington 197
Los Angeles 178
Chandler 154
Beijing 151
New York 144
Toronto 141
Santa Clara 138
Dublin 132
Hefei 131
Fairfield 128
Council Bluffs 116
Haiphong 116
Boardman 110
Chicago 100
Seoul 98
Biên Hòa 92
Da Nang 90
Ha Long 90
Columbus 87
Vienna 83
Woodbridge 78
Hải Dương 75
Quận Bình Thạnh 75
Houston 72
Jakarta 71
Dearborn 67
Rome 64
Buffalo 63
Princeton 58
Ninh Bình 56
The Dalles 54
Thái Nguyên 53
São Paulo 51
Lauterbourg 49
Can Tho 48
Vũng Tàu 47
Shanghai 44
Quận Một 43
Seattle 43
Bắc Giang 42
Bắc Ninh 41
Cambridge 40
Jacksonville 39
Munich 39
London 37
Quận Phú Nhuận 37
Vilnius 36
Helsinki 35
Moscow 35
Orem 35
Chennai 33
Phủ Lý 32
Warsaw 32
Tokyo 30
Quận Sáu 29
Pune 27
Montreal 26
Nanjing 25
Điện Bàn 25
Brooklyn 24
Turin 23
Kaohsiung 22
Nuremberg 22
Quảng Ninh 22
Boston 21
Kent 21
Vinh 21
Phoenix 20
Quận Bảy 20
Appiano Gentile 19
Lang Son 19
Poplar 19
Rio de Janeiro 19
San Diego 19
Stockholm 19
Lawrence 18
Brussels 17
Denver 17
Johannesburg 17
Manchester 17
Mexico City 17
Thu Dau Mot 17
Zurich 17
Brasília 16
Lappeenranta 16
Thái Bình 16
Florence 15
Pavia 15
Quận Mười 15
Baghdad 14
Totale 12.249
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.147
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 767
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 627
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 626
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 557
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 511
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 497
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 463
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 449
EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS 432
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 413
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 407
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 399
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 387
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 380
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 359
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 355
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 334
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 334
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 330
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 323
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 323
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 317
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 315
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 308
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 299
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 299
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 291
Neurodegeneration: can metabolites from Eremurus persicus help? 289
The Role of NMNAT2/SARM1 in Neuropathy Development 288
Are sigma receptor modulators a weapon against multiple sclerosis disease? 288
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 285
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 279
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 277
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 276
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 272
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 262
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 261
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 256
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 254
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 253
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 252
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 250
Rigosertib and cholangiocarcinoma: A cell cycle affair 243
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 240
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 240
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 218
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 217
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 211
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 197
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 177
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 170
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 160
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 102
Molecular Mechanisms of Proteasome Inhibitor-Induced Peripheral Neuropathy 87
Recent advances in the discovery of ALKBH 1–8 inhibitors 67
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicity 67
MECHANISTIC IMPLICATIONS OF TUBULIN POST- TRANSLATIONAL MODIFICATIONS IN A PRECLINICAL MODEL OF PROTEASOME INHIBITOR- INDUCED PERIPHERAL NEUROPATHY 55
Proteasome inhibitors-based chemotherapy-induced neurotoxicity: mitochondrial, calcium signalling and cytoskeleton alterations 49
Role of the Sodium–Calcium Exchanger NCX2 in Oxaliplatin-Induced Peripheral Neurotoxicity 33
From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation 29
Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib 24
Totale 18.877
Categoria #
all - tutte 50.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022580 0 92 77 53 42 56 30 30 20 25 50 105
2022/20231.012 94 221 158 88 80 121 31 63 55 21 52 28
2023/2024668 24 23 31 23 65 138 91 37 48 21 7 160
2024/20252.793 183 175 189 134 263 180 188 90 296 362 238 495
2025/202610.838 3.240 1.378 1.108 785 632 355 1.020 314 495 618 414 479
2026/2027579 438 141 0 0 0 0 0 0 0 0 0 0
Totale 18.877